Literature DB >> 34128570

Uncovering the Hidden Landscape of Tris(4-pyridyl) Ligands: Topological Complexity Derived from the Bridgehead.

Jessica E Waters1, Georg Berger1,2, Andrew J Peel1, Raúl García-Rodríguez3, Andrew D Bond1, Dominic S Wright1.   

Abstract

Supramolecular main group chemistry is a developing field which parallels the conventional domain of metallo-organic chemistry. Little explored building blocks in this area are main group metal-based ligands which have the appropriate donor symmetry to build desired molecular or extended arrangements. Tris(pyridyl) main group ligands (E(py)3 , E=main group metal) are potentially highly versatile building blocks since shifting the N-donor arms from the 2- to the 3-positions and 4-positions provides a very simple way of changing the ligand character from mononuclear/chelating to multidentate/metal-bridging. Here, the coordination behaviour of the first main group metal tris(4-pyridyl) ligands, E(4-py)3 (E=Sb, Bi, Ph-Sn) is explored, as well as their ability to build metal-organic frameworks (MOFs). The complicated topology of these MOFs shows a marked influence on the counter anion and on the ability of the E(4-py)3 ligands to switch coordination mode, depending on the steric and donor character of the bridgehead. This structure-directing influence of the bridgehead provides a potential building strategy for future molecular and MOF design in this area.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  coordination networks; main-group synthesis; pnictogens; topology; tripodal ligands

Year:  2021        PMID: 34128570     DOI: 10.1002/chem.202101291

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Cation- and Anion-Mediated Supramolecular Assembly of Bismuth and Antimony Tris(3-pyridyl) Complexes.

Authors:  Álvaro García-Romero; Jose M Martín-Álvarez; Daniel Miguel; Dominic S Wright; Celedonio M Álvarez; Raúl García-Rodríguez
Journal:  Inorg Chem       Date:  2021-12-09       Impact factor: 5.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.